Brawn Biotech Limited (BRAWN.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹25.40 (+0.00%) as of
Key statistics
- Market cap
- 76.21M
- P/E (TTM)
- 8.79
- EPS (TTM)
- 2.89
- Dividend yield
- 0.00%
- 52-week range
- 17.71 – 25.70
- Beta
- 0.13
- Revenue (TTM)
- 172.59M
- Profit margin
- 4.98%
- Volume
- 4.00
About Brawn Biotech Limited
Brawn Biotech Limited trades in pharmaceutical products in India. It provides pharmaceutical formulations, including antibacterial, cardiovascular, antidiabetic, analgesic, gastrointestinal, antifungal, skin care, antipsychotic, antiasthmatic, antacid, antimalarial, and nutritional products. The company was formerly known as Brawn Pharmaceuticals Limited and changed its name to Brawn Biotech Limited in November 2010. The company was incorporated in 1985 and is based in New Delhi, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- New Delhi, India
- Employees
- 6
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.